Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.77) per share. This is a 7.23 percent increase over losses of $(0.83) per share from the same period last year.
Gainers
Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
Akero Therapeutics Inc (NASDAQ:AKRO) announced a $25 million equity investment by Pfizer Inc (NYSE:PFE) at $9.90 per share. The company also announced a…
Akero Therapeutics (NASDAQ:AKRO) reported its Q1 earnings results on Friday, May 6, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.